Nevada 2023 Regular Session

Nevada Assembly Bill AB155

Introduced

2/13/23

Refer

2/13/23

Report Pass

4/24/23

Refer

4/25/23

Report Pass

6/2/23

Engrossed

6/3/23

Refer

6/3/23

Report Pass

6/4/23

Enrolled

6/9/23

Chaptered

6/13/23

Passed

6/13/23

Caption

Establishes provisions relating to biomarker testing. (BDR 40-305)

Latest NV AB155 Activity

View All Events: NV 2023 Regular Session AB155

Companion Bills

No companion bills found.

Previously Filed As

NV AB382

Revises provisions relating to health insurance coverage for biomarker testing. (BDR 57-913)

NV SB192

Revises provisions relating to public health. (BDR 40-86)

NV SB439

Revises provisions relating to communicable diseases. (BDR 40-987)

NV SB496

Biomarker testing.

NV AB74

Revises provisions relating to insurance. (BDR 57-256)

NV SB912

Biomarker testing.

NV SB377

Establishes provisions relating to health insurance. (BDR 57-1083)

NV SB337

Revises provisions relating to opioids. (BDR 40-204)

NV AB156

Revises provisions relating to substance use disorders. (BDR 40-331)

NV SB165

Establishes provisions relating to behavioral health. (BDR 54-145)

Similar Bills

NJ A4163

Requires health insurers to provide coverage for biomarker precision medical testing.

NJ S3098

Requires health insurers to provide coverage for biomarker precision medical testing.

WV HB4753

Relating to providing health insurance coverage concerning biomarker testing

NV AB382

Revises provisions relating to health insurance coverage for biomarker testing. (BDR 57-913)

DE SB120

An Act To Amend Titles 18, 29, And 31 Of The Delaware Code Relating To Health Insurance.

FL H0805

Health Insurance Coverage for Biomarker Testing

CA SB496

Biomarker testing.

CA SB912

Biomarker testing.